Articles tagged with Blood Vessels
A significant increase in MMP-1, an enzyme produced in tissues under conditions of inflammation, was found in the blood vessels of women with preeclampsia, explaining edema and proteinuria. This finding also suggests a new mechanism for hypertension, with PAR1 activation potentially causing blood vessel contraction.
A new type of VEGFR-3 blocking antibody has been developed to inhibit angiogenesis in cancerous tumors. The antibody was shown to be effective even at high concentrations of the growth factor, and combining it with another inhibitor provided synergistic inhibition.
Researchers are developing a manufacturing platform to produce biodegradable frames that mimic nature's fine-grained details, including vasculature. The goal is to grow replacement cardiac tissues for people who have suffered a heart attack, and create better systems for growing and studying cells in the laboratory.
Researchers discovered that GPR124 controls the growth of blood vessels into the developing brains of mice embryos. The protein is essential for normal blood vessel development in the nervous system but can lead to abnormal hypervasculature when overexpressed.
A randomized trial found that mycophenolate mofetil was less effective than azathioprine in preventing relapses of antineutrophil cytoplasmic antibody-associated vasculitis. The study involved 156 patients with newly diagnosed AAV and followed them for a median of 39 months.
Researchers at Washington University School of Medicine discovered a new drug target that can improve the effectiveness of radiation therapy for hard-to-treat cancers. The enzyme cytosolic phospholipase A2 (cPLA2) promotes tumor angiogenesis, enabling tumors to overcome radiation effects.
Researchers found that secondhand smoke triggers a complex inflammatory response in the lungs of rats, leading to increased white blood cells, damaged lung tissue, and impaired immune function. The study suggests potential implications for treating damage caused by secondhand smoke in humans.
Researchers at the University of Louisville have developed a new technology that prevents scar tissue from forming around implanted devices, allowing them to function longer. The technology uses tiny blood vessel fragments suspended in collagen gel to create an environment that resists scarring.
Researchers discovered that galectin-3 promotes angiogenesis by binding to specific cell-adhesion proteins, suggesting potential therapeutic targets. Targeting the protein with inhibitors significantly reduced angiogenesis in mice, offering new approaches for treating diseases caused by excessive blood vessel growth.
A study by LMU researchers found that neutrophils play a crucial role in blood coagulation and antimicrobial defense, trapping pathogens in small blood vessels. Excessive clotting, however, can lead to life-threatening conditions like heart attack and stroke.
A recent study found that long-term dietary consumption of capsaicin in chili peppers can reduce blood pressure in genetically hypertensive rats by activating the TRPV1 channel and increasing nitric oxide production. This could lead to potential benefits for humans with high blood pressure.
Researchers at UC San Diego School of Medicine identify microRNA miR-132 as the 'gas pedal' controlling uncontrolled blood vessel growth. They develop an anti-miR therapy to restore functionality to the 'brake,' halting disease progression in mouse models of cancer and retinal disorders.
Researchers found that chronic morphine use decreases levels of tumor angiogenesis, mediated by suppression of signaling induced by low oxygen concentrations. This effect suggests morphine may inhibit tumor growth and serve as an anti-angiogenic agent in cancer pain management.
Daily cocoa flavanol consumption more than doubles the number of circulating angiogenic cells in the blood, increasing vessel repair and maintenance functions. High-flavanol cocoa also reduces systolic blood pressure and improves blood vessel function by 47%.
The International Society for Heart and Lung Transplantation has developed a standardized nomenclature for cardiac allograft vasculopathy, which will benefit heart transplant patients. The new classification system defines four levels of CAV severity, allowing for more accurate treatment options and improved patient outcomes.
Researchers found that resveratrol inhibits formation of damaging blood vessels in the eye, a potential preventive therapy for blinding diseases. The compound's novel pathway could become a new target for therapies for eye disease and other problems related to abnormal angiogenesis.
A recent study of 700,000 people found that diabetes approximately doubles the risk of developing blood vessel diseases, including heart attacks and strokes. The disease is now estimated to be responsible for 325,000 cardiovascular deaths per year in industrialized countries.
Researchers identified a defective signaling pathway that leads to the development of vascular malformations in the brain. The study suggests that targeting this pathway may lead to new treatments for cerebral cavernomas, including the use of anticancer drugs.
A recent NIH-supported study has discovered a novel pathway that may lead to the development of new treatments for high blood pressure. By increasing certain proteins in mouse blood vessels, researchers were able to relax the vessels and lower blood pressure, reducing damage to the kidneys compared to normal mice.
Researchers observed that early blood flow begins all at once in zebrafish embryos, involving hundreds of cells. Red blood cells initially stick to the vessel wall before releasing themselves with a protease enzyme called ADAM8.
A DNA-vaccine targeting DLL4 inhibits the formation of new blood vessels in tumours, leading to reduced tumour growth. The vaccine was shown to be effective in mice with breast cancer, causing a tightly packed network of non-functional blood vessels and poor blood supply.
The protein tPA provides protection for nerve cells in the hippocampus by preventing death caused by reduced blood flow during stroke. Analysis of tPA's protective process reveals implications for therapeutic strategies to prevent nerve cell death.
A new study reveals increasing rates of age-related macular degeneration among Asians, comparable to Caucasians. An innovative laser surgery called 'bypass' has shown promise in improving vision outcomes for central retinal vein occlusion patients.
Researchers have identified SphK1 and SphK2 as crucial proteins involved in generating the molecule S1P, which affects blood vessels and the immune system. Mice lacking these proteins showed improved recovery from anaphylaxis, while those lacking only SphK1 recovered poorly.
Researchers at UMass Chan Medical School have identified a novel microRNA-mediated genetic pathway responsible for triggering vascular growth in zebrafish embryos. This discovery provides new insights into how vascular systems develop and may offer a potential therapeutic target for limiting blood vessel formation in solid cancers.
Researchers have discovered that infantile hemangiomas originate from stem cells. Steroids target these stem cells specifically, inhibiting their ability to stimulate blood vessel growth. This finding opens the way for more specific and safer therapies for hemangioma.
A new study identifies a protein pathway that protects blood vessels from hyper-inflammatory response to infection, reducing mortality rates in mouse models of avian flu and sepsis by up to 50%. The researchers found that activating the Robo4 pathway stabilizes blood vessels, preventing leakage and tissue damage.
Researchers at Karolinska Institutet identified the role of VEGF-B protein in regulating fatty acid transport proteins in blood vessel walls, leading to increased fat intake and potential new treatments for metabolic diseases. The study found that blocking VEGF-B signalling may reduce insulin resistance and blood glucose levels.
Researchers identified IFN-beta as a natural inhibitor of tumor blood vessel growth, limiting tumor growth and immune cell gene expression. This discovery provides insight into why IFN therapy benefits early cancer development.
A new chemical compound has been discovered that may help treat and prevent diastolic heart failure, a condition where the heart is unable to relax after contraction. The research found that adding tetrahydrobiopterin (BH4) to blood vessels can restore function to the heart and prevent the disease from developing.
Researchers at Imperial College London have made a groundbreaking discovery that could lead to new treatments for conditions like deep vein thrombosis and haemophilia A. The study found that factor VIII, a key protein in blood clotting, is produced by lung blood vessels rather than just the liver.
A study by University of Cincinnati researchers found that proapoptotic peptide treatment reduced food intake and fat loss in obese mice and rats, without affecting energy expenditure. The findings suggest a novel system informing brain activity about fat tissue size, influencing appetite and weight regulation.
Interleukin-6 is a key mediator of inflammation in diabetic retinopathy, inducing vascular inflammation and tissue destruction. An interleukin-6 antibody may prevent damage by targeting this inflammatory response.
Researchers block COUP-TFII to suppress tumor blood vessel growth and tumor formation. This discovery identifies a new pathway for fighting tumors and offers hope for developing new treatments, including antagonists that can intervene to halt tumor growth.
Scientists discovered that blocking delta-catenin expression disrupts inflammation-induced angiogenesis in tumors and wounds. The findings suggest that delta-catenin may be a key player in cancer progression.
Researchers have identified Notch signaling pathway activation in human angiomyolipomas and TSC2-deficient rat cells, suggesting that TSC proteins regulate Notch activity. This finding supports the idea that Notch dysregulation may underlie some of the distinctive clinical features of Tuberous Sclerosis Complex.
Researchers have identified a key protein channel that helps nerve sensors regulate blood pressure. The ASIC2 channel plays a crucial role in controlling electrical activity in blood vessels, and its absence leads to high blood pressure.
A study led by Dr. Frank Winkler followed the steps of tumor cell formation in real-time, revealing four stages required for metastasis development. Blocking angiogenesis with Avastin can suppress emergence of brain metastases.
Researchers at Karolinska Institutet identify polyphosphate as a key player in the formation of blood clots and inflammation. The study suggests that phosphatases can break down polyphosphate, preventing both conditions.
Researchers identified a new mechanism by which HRG protein inhibits angiogenesis and tumor growth in cancer patients. The study shows that the HRG fragment binds to endothelial cells and platelets, creating a microenvironment that functions as an angiogenesis inhibitor.
Researchers found that surfboard-shaped nanoparticles stay closest to blood vessel walls, offering a potential solution for targeted cancer therapy. The study suggests that current transfusion techniques may not be ideal, and alternative methods could establish proper blood arrangement faster.
Scientists observe aggressive T-cells breaching blood-brain barrier, crawling along vascular walls and forming connections with phagocytes. This breakthrough understanding may aid in developing new treatments for multiple sclerosis.
Researchers at Johns Hopkins School of Medicine found that cells in the retina can remain alive for many months and recover some or all normal function even without a proper blood supply. The study suggests that restoring blood supply to deprived regions of the retina may restore visual function.
Researchers at Case Western Reserve University are developing a novel approach to building vascular networks in engineered tissues using custom-designed synthetic molecules and embryonic stem cells. Their goal is to produce networks that can grow and maintain themselves like natural blood vessels, paving the way for improved human lives.
Researchers from BUSM found that the 940nm wavelength laser is more effective in treating facial telangiectasias due to its superior penetration of the dermis and slower heating of vessels. This results in less pain and side effects compared to the 532nm wavelength.
Researchers at the University of Iowa discovered a way to deliver therapeutic molecules directly into brain cells using the blood-brain barrier. They found that unique alterations in the blood vessels surrounding brain cells can target specific diseases, allowing for non-invasive treatment of lysosomal storage diseases.
A new corticosteroid medication has been shown to improve vision and reduce vision loss in patients with central retinal vein occlusion. The treatment, which involves eye injections of the medication, has been proven effective in reducing vision loss by five times.
Blood vessels can spur their own growth and deliver oxygen to tissues and tumors through internal cues. The study found that a protein called Flt-1 plays a key role in regulating this process.
Researchers found that the endothelin receptor plays a role in vaso-occlusive pain in sickle cell disease, with males more sensitized to pain. Females have more of the ETB receptor, which may explain better pain control and reduced sensitivity.
The International Conference on Endothelin presented promising results for new endothelin receptor antagonist drugs, which may benefit conditions like kidney disease and pulmonary hypertension. However, challenges in determining the best treatment approach and addressing potential side effects must be overcome.
Researchers found that mice lacking protein S suffered massive blood clots and defective blood vessels, highlighting the protein's dual role in coagulation and inflammation. Protein S also binds to receptors that regulate immune responses, suggesting new targets for gene therapy.
GS-101 demonstrates significant inhibition and regression of corneal neovascularisation in a phase II study. The treatment is generally well-tolerated with no serious side effects, offering a new approach to managing ophthalmic angiogenesis.
A preclinical study suggests that ancient Chinese herbal formulas have profound nitric oxide bioactivity, which can signal blood vessel relaxation and eliminate clots. The findings offer new hope for cardiovascular disease prevention and treatment.
Researchers found that elevated arginase levels contribute to vascular eye damage in diabetic retinopathy by reducing nitric oxide production. Normalizing arginase levels could potentially halt disease progression by preventing inflammation and vascular constriction.
A new molecule known as soluble VEGFR-2 has been identified that selectively blocks lymphatic vessel growth but not blood vessel growth. This breakthrough could lead to targeted treatments for diseases such as lymphedema, transplant rejection, and tumor metastasis.
Concurrent deep vein thrombosis is more likely when superficial vein thrombosis affects the lower leg, according to a study published in Archives of Dermatology. The study found that 24% of patients with superficial vein thrombosis also had deep vein thrombosis.
Researchers have discovered that two microRNAs, miR-143 and miR-145, control the differentiation and growth of vascular smooth muscle cells. These findings suggest that targeting these microRNAs may be a potential treatment for diseases such as atherosclerosis and Alzheimer's disease.
Researchers at the University of Oklahoma Health Sciences Center discovered a natural compound that restores balance in the eye to stop diabetic retinopathy, a disease affecting five million Americans. The treatment prevents leakage, blocks inflammation, and stops unwanted blood vessel growth.
Researchers found 128 genes with varying expression levels in early clinical pregnancy compared to non-pregnant state. Gene expressions related to angiogenesis, vascular endothelial growth factor, and pyruvate metabolism were over-represented.
A team of researchers led by Dr. Jayakrishna Ambati at the University of Kentucky has discovered a biological marker for neovascular age-related macular degeneration (AMD). The marker, CCR3, shows strong potential as a means for both early detection and preventive treatment.